Carregant...
A new alpha in line between KRAS and NF-κB activation?
Bang and colleagues report a novel role for GSK-3α, rather than GSK-3β, as the link between KRAS activating mutations and the canonical and non-canonical activation pathways of NF-κB in pancreatic cancer.
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3746833/ https://ncbi.nlm.nih.gov/pubmed/23749528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0193 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|